These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6432691)

  • 1. Conversion of the C3 component of complement in sera of hanseniasis patients.
    Kliemann TA; Martinez EL; Irulegui I; de Souza ZW; Cavalcanti ZM
    Hansenol Int; 1983 Jun; 8(1):5-8. PubMed ID: 6432691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of the C3 component of complement in mice infected with Trypanosoma cruzi.
    Irulegui I; Chaves J; Ferri RG; de Souza ZW; de Souza HB; Castilho EA
    Rev Inst Med Trop Sao Paulo; 1980; 22(2):62-8. PubMed ID: 6776614
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced complement-mediated immune complex solubilization in leprosy patients.
    Ramanathan VD; Sharma P; Ramu G; Sengupta U
    Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
    J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of in vitro administered immune complexes on serum levels of complement and circulating immune complexes in Mycobacterium leprae infected mice.
    Vaishnavi C; Ganguly NK; Kaur S; Singh M; Kumar B
    Indian J Exp Biol; 1988 Jan; 26(1):9-12. PubMed ID: 3042618
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of postmortem interval based on the third component of complement (C3) cleavage.
    Kominato Y; Harada S; Yamazaki K; Misawa S
    J Forensic Sci; 1988 Mar; 33(2):404-9. PubMed ID: 3373157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
    Valentijn RM; Faber WR; Lai A Fat RF; Chan Pin Jie JC; Daha MR; van Es LA
    Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological properties of immune complexes.
    Daha MR
    Neth J Med; 1984; 27(9):375-9. PubMed ID: 6392911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M
    Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune complex in the wall of the gallbladder in patients with cholelithiasis: deposition and its pathological significance].
    Yang Y
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 30(11):645-7, 698. PubMed ID: 1307287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.